Tactile Systems Technology, Inc. Increase (Decrease) in Employee Related Liabilities
Tactile Systems Technology, Inc. (TCMD) reported Increase (Decrease) in Employee Related Liabilities of -$3.76 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities · last filed 2026-08-10
- Tactile Systems Technology, Inc. increase (decrease) in employee related liabilities for the quarter ending 2026-06-30 was $4.57M, a 161.52% increase year-over-year.
- Tactile Systems Technology, Inc. increase (decrease) in employee related liabilities for the quarter ending 2026-03-31 was -$8.34M.
- Tactile Systems Technology, Inc. increase (decrease) in employee related liabilities for the quarter ending 2025-12-31 was $4.65M, a 3.85% decline year-over-year.
- Tactile Systems Technology, Inc. increase (decrease) in employee related liabilities for the quarter ending 2025-09-30 was $2.05M, a 105.72% increase year-over-year.
- Tactile Systems Technology, Inc. increase (decrease) in employee related liabilities for fiscal 2025 was $1.46M, a 28.31% increase from fiscal 2024.
- Tactile Systems Technology, Inc. increase (decrease) in employee related liabilities for fiscal 2024 was $1.13M.
- Tactile Systems Technology, Inc. increase (decrease) in employee related liabilities for fiscal 2023 was -$311.00K, a 106.27% decline from fiscal 2022.
- Tactile Systems Technology, Inc. increase (decrease) in employee related liabilities for fiscal 2022 was $4.96M, a 800.36% increase from fiscal 2021.
| Period end | Increase (Decrease) in Employee Related Liabilities 3 month | Increase (Decrease) in Employee Related Liabilities 6 month | Increase (Decrease) in Employee Related Liabilities 9 month | Increase (Decrease) in Employee Related Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$3.76M 10-Q · filed 2026-08-10 | $888.00K derived: sum of 3 quarters · filed 2026-08-10 | $2.94M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | -$8.34M 10-Q · filed 2026-05-04 | -$3.69M derived: sum of 2 quarters · filed 2026-05-04 | -$1.64M derived: sum of 3 quarters · filed 2026-05-04 | $112.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $4.65M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $6.70M derived: sum of 2 quarters · filed 2026-02-17 | $8.45M derived: sum of 3 quarters · filed 2026-08-10 | $1.46M 10-K · filed 2026-02-17 |
| 2025-09-30 | $2.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $3.80M derived: sum of 2 quarters · filed 2026-08-10 | -$3.20M 10-Q · filed 2025-11-03 | $1.64M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $1.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$5.25M 10-Q · filed 2026-08-10 | -$408.00K derived: sum of 3 quarters · filed 2026-08-10 | $588.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | -$6.99M 10-Q · filed 2026-05-04 | -$2.16M derived: sum of 2 quarters · filed 2026-05-04 | -$1.16M derived: sum of 3 quarters · filed 2026-05-04 | -$94.00K derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $4.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $5.83M derived: sum of 2 quarters · filed 2026-02-17 | $6.90M derived: sum of 3 quarters · filed 2026-02-17 | $1.13M 10-K · filed 2026-02-17 |
| 2024-09-30 | $996.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $2.06M derived: sum of 2 quarters · filed 2025-11-03 | -$3.70M 10-Q · filed 2025-11-03 | -$1.70M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | $1.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | -$4.70M 10-Q · filed 2025-08-04 | -$2.69M derived: sum of 3 quarters · filed 2026-02-17 | -$1.71M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | -$5.77M 10-Q · filed 2025-05-05 | -$3.76M derived: sum of 2 quarters · filed 2026-02-17 | -$2.78M derived: sum of 3 quarters · filed 2026-02-17 | -$441.00K derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $2.99M derived: sum of 2 quarters · filed 2026-02-17 | $5.33M derived: sum of 3 quarters · filed 2026-02-17 | -$311.00K 10-K · filed 2026-02-17 |
| 2023-09-30 | $984.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $3.32M derived: sum of 2 quarters · filed 2024-11-04 | -$2.32M 10-Q · filed 2024-11-04 | $1.21M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $2.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | -$3.30M 10-Q · filed 2024-08-05 | $225.00K derived: sum of 3 quarters · filed 2025-02-18 | $1.66M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | -$5.64M 10-Q · filed 2024-05-06 | -$2.11M derived: sum of 2 quarters · filed 2025-02-18 | -$680.00K derived: sum of 3 quarters · filed 2025-02-18 | $1.98M derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | $3.52M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $4.96M derived: sum of 2 quarters · filed 2025-02-18 | $7.62M derived: sum of 3 quarters · filed 2025-02-18 | $4.96M 10-K · filed 2025-02-18 |
| 2022-09-30 | $1.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $4.09M derived: sum of 2 quarters · filed 2023-11-06 | $1.44M 10-Q · filed 2023-11-06 | $3.25M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-06-30 | $2.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $5.00K 10-Q · filed 2023-08-07 | $1.82M derived: sum of 3 quarters · filed 2024-02-20 | $1.84M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-03-31 | -$2.66M 10-Q · filed 2023-05-08 | -$841.00K derived: sum of 2 quarters · filed 2024-02-20 | -$822.00K derived: sum of 3 quarters · filed 2024-02-20 | $934.00K derived: sum of 4 quarters · filed 2024-02-20 |
| 2021-12-31 | $1.82M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $1.84M derived: sum of 2 quarters · filed 2024-02-20 | $3.59M derived: sum of 3 quarters · filed 2024-02-20 | $551.00K 10-K · filed 2024-02-20 |
| 2021-09-30 | $19.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $1.77M derived: sum of 2 quarters · filed 2022-11-07 | -$1.27M 10-Q · filed 2022-11-07 | -$542.00K derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-06-30 | $1.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-01 | -$1.28M 10-Q · filed 2022-08-01 | -$561.00K derived: sum of 3 quarters · filed 2023-02-21 | $3.33M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-03-31 | -$3.04M 10-Q · filed 2022-05-02 | -$2.32M derived: sum of 2 quarters · filed 2023-02-21 | $1.58M derived: sum of 3 quarters · filed 2023-02-21 | $253.00K derived: sum of 4 quarters · filed 2023-02-21 |
| 2020-12-31 | $724.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $4.62M derived: sum of 2 quarters · filed 2023-02-21 | $3.29M derived: sum of 3 quarters · filed 2023-02-21 | $1.49M 10-K · filed 2023-02-21 |
| 2020-09-30 | $3.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $2.57M derived: sum of 2 quarters · filed 2021-11-08 | $766.00K 10-Q · filed 2021-11-08 | -$472.00K derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-06-30 | -$1.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-02 | -$3.13M 10-Q · filed 2021-08-02 | -$4.37M derived: sum of 3 quarters · filed 2022-02-23 | -$35.00K derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-03-31 | -$1.80M 10-Q · filed 2021-05-03 | -$3.04M derived: sum of 2 quarters · filed 2022-02-23 | $1.29M derived: sum of 3 quarters · filed 2022-02-23 | $1.46M derived: sum of 4 quarters · filed 2022-02-23 |
| 2019-12-31 | -$1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $3.09M derived: sum of 2 quarters · filed 2022-02-23 | $3.26M derived: sum of 3 quarters · filed 2022-02-23 | $2.68M 10-K · filed 2022-02-23 |
| 2019-09-30 | $4.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $4.50M derived: sum of 2 quarters · filed 2020-11-02 | $3.92M 10-Q · filed 2020-11-02 | $3.04M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-06-30 | $169.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-03 | -$415.00K 10-Q · filed 2020-08-03 | -$1.29M derived: sum of 3 quarters · filed 2021-02-23 | $1.49M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-03-31 | -$584.00K 10-Q · filed 2020-05-04 | -$1.46M derived: sum of 2 quarters · filed 2021-02-23 | $1.32M derived: sum of 3 quarters · filed 2021-02-23 | $1.98M derived: sum of 4 quarters · filed 2021-02-23 |
| 2018-12-31 | -$871.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $1.90M derived: sum of 2 quarters · filed 2021-02-23 | $2.56M derived: sum of 3 quarters · filed 2021-02-23 | $715.00K 10-K · filed 2021-02-23 |
| 2018-09-30 | $2.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $3.44M derived: sum of 2 quarters · filed 2019-11-04 | $1.59M 10-Q · filed 2019-11-04 | $2.41M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-06-30 | $664.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | -$1.19M 10-Q · filed 2019-08-05 | -$360.00K derived: sum of 3 quarters · filed 2020-02-26 | $2.40M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-03-31 | -$1.85M 10-Q · filed 2019-05-06 | -$1.02M derived: sum of 2 quarters · filed 2020-02-26 | $1.74M derived: sum of 3 quarters · filed 2020-02-26 | -$30.00K derived: sum of 4 quarters · filed 2020-02-26 |
| 2017-12-31 | $826.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $3.59M derived: sum of 2 quarters · filed 2020-02-26 | $1.82M derived: sum of 3 quarters · filed 2020-02-26 | $14.00K 10-K · filed 2020-02-26 |
| 2017-09-30 | $2.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $994.00K derived: sum of 2 quarters · filed 2018-11-05 | -$812.00K 10-Q · filed 2018-11-05 | $1.63M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | -$1.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | -$3.57M 10-Q · filed 2018-08-06 | -$1.13M derived: sum of 3 quarters · filed 2019-02-28 | $1.13M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | -$1.81M 10-Q · filed 2018-05-07 | $636.00K derived: sum of 2 quarters · filed 2019-02-28 | $2.90M derived: sum of 3 quarters · filed 2019-02-28 | $3.06M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $2.44M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $4.71M derived: sum of 2 quarters · filed 2019-02-28 | $4.87M derived: sum of 3 quarters · filed 2019-02-28 | $3.34M 10-K · filed 2019-02-28 |
| 2016-09-30 | $2.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $2.43M derived: sum of 2 quarters · filed 2017-11-07 | $895.00K 10-Q · filed 2017-11-07 | $2.00M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-06-30 | $166.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | -$1.37M 10-Q · filed 2017-08-07 | -$262.00K derived: sum of 3 quarters · filed 2018-02-26 | $414.00K derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-03-31 | -$1.53M 10-Q · filed 2017-05-08 | -$428.00K derived: sum of 2 quarters · filed 2018-02-26 | $248.00K derived: sum of 3 quarters · filed 2018-02-26 | |
| 2015-12-31 | $1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $1.78M derived: sum of 2 quarters · filed 2018-02-26 | $1.35M 10-K · filed 2018-02-26 | |
| 2015-09-30 | $676.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $246.00K 10-Q · filed 2016-11-10 | ||
| 2015-06-30 | -$430.00K 10-Q · filed 2016-09-07 | |||
| 2014-12-31 | -$601.00K 10-K · filed 2017-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B |